吸入用治療剤 - Shira Therapeutic Incorporated

Title:

吸入用治療剤

Document Type and Number:

Japanese Patent JP2023539590

Kind Code:

A

Abstract:

本明細書では、組成物及びその使用方法について説明する。当該組成物は、第一の吸入用粒子の集団と、第二の吸入用粒子の集団とを含み、第一の吸入用粒子は、第一の生分解性カプセル剤内に含まれる第一の粘液溶解剤を含み、第二の吸入用粒子の集団は、第二の生分解性カプセル剤内に含まれる第一または第二の粘液溶解剤を含む。【選択図】なし

More Like This:

JPH03501852	[Title of the Invention] Prevention and a therapeutic method of fungus infection of a lung using aerosol-ized polyene
JP2015110631	EXCELLENT CONTROL OF BLOOD GLUCOSE IN DIABETES TREATMENT
WO/2023/240364	HOMOGENEOUS EXTRACT-INFUSED CANNABIS PRODUCTS AND METHODS FOR PREPARATION THEREOF

Inventors:

Rizvi, Safia
underwood, dennis

Application Number:

JP2023513338A

Publication Date:

September 15, 2023

Filing Date:

August 26, 2021

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Shira Therapeutic Incorporated

International Classes:

A61K9/72; A61K9/12; A61K31/185; A61K38/46; A61K47/02; A61K47/10; A61K47/18; A61K47/24; A61K47/26; A61K47/36; A61K47/38; A61P11/12

Attorney, Agent or Firm:

Patent Attorney Corporation Hiraki International Patent Office

Previous Patent: Treatment of non-small cell lung cancer with EGFR mutations

Next Patent: BCMA chimeric antigen receptor